Alpha 2.0
Login Register
» Authors » Ismail Mohamed El Mancy

Ismail Mohamed El Mancy

Explore the profile of Ismail Mohamed El Mancy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 12
Followers 0
Related Specialties
General Medicine
Pharmacology
Gastroenterology
Top 10 Co-Authors
Ibrahim Ghounim Ramadan Mohamed
Essam Kotb
Ahmed Eliwa
Farag Khalil
Sadek Mostafa
Hosam Shabana
Esam M Ghamry
Mostafa Sabrh
Ibrahim Ghounim Ramadan
Ahmed Elmoursi
Published In
Int J Clin Pract
Turk J Gastroenterol
High Blood Press Cardiovasc Prev
Endocr Metab Immune Disord Drug Targets
Int J Gen Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Relation between erythropoietin resistance and metabolic syndrome in hemodialysis patients: A multicentric propensity score matched analysis
Kotb E, El Mancy I, Mohamed I, Ayoub H, Rashed A, El-Nasser W, et al.
J Investig Med . 2023 May; 71(7):753-759. PMID: 37199290
Erythropoietin (EPO) resistance is frequently reported in hemodialysis (HD) patients. Metabolic syndrome (MetS) is a common biochemical condition that comprises central obesity, dyslipidemia, hypertension, and hyperglycemia. The present study aimed...
2.
Relationship between Subclinical Hypothyroidism and Uremic Pruritis in Hemodialysis Patients
Kotb E, El Mancy I, Mohamed I, Ayoub H, Rashed A, El-Nasser W, et al.
Endocr Metab Immune Disord Drug Targets . 2023 May; 24(2):235-241. PMID: 37165587
Background And Aim: Uremic pruritus (UP) is one of the most distressing symptoms in hemodialysis (HD) patients. Subclinical hypothyroidism (SCH) is a biochemical condition with high prevalence in HD patients....
3.
Efficacy and Safety of Rifaximin in the Prevention of Recurrent Episodes of Hepatic Encephalopathy: A Systematic Review and Meta-analysis
Elmoursi A, Abdelsattar A, Khalil F, Shabana H, Zedan H, El Mancy I, et al.
Turk J Gastroenterol . 2023 Apr; 34(6):584-592. PMID: 37051626
Background: Rifaximin is an oral antimicrobial drug with a broad-spectrum effect. It locally regulates the function and structure of intestinal bacteria and decreases intestinal endotoxemia. We aimed to investigate the...
4.
Relation Between Non-Alcoholic Fatty Pancreas and Clinical and Biochemical Parameters in Women with Polycystic Ovary Syndrome: A Multi-Centric Study
Osman M, Alkhouly M, Elmohaseb G, Nassef E, Mohamed I, El Mancy I, et al.
Int J Gen Med . 2022 Nov; 15:8225-8233. PMID: 36438020
Background: Polycystic ovary syndrome (PCOS) is the most common endocrinological disease affecting women in the reproductive age. Non-alcoholic fatty pancreas disease (NAFPD) can promote many aspects of pancreatic dysfunction. The...
5.
Evaluation of the Safety and Efficacy of Dual Therapy Perindopril/Amlodipine in the Management of Hypertension. A Systematic Review and Meta-Analysis
Mostafa S, Shabana H, Khalil F, El Mancy I, Zedan H, Elmoursi A, et al.
High Blood Press Cardiovasc Prev . 2022 Oct; 29(6):565-576. PMID: 36287359
Introduction: Hypertension represent the commonest cause of death in 2017. Hypertension is classified into two types which are primary or essential hypertension and secondary hypertension. The perindopril-amlodipine combination showed a...
6.
Serum Endocan Levels and Subclinical Atherosclerosis in Patients with Chronic Kidney and End-Stage Renal Diseases
El-Senosy F, Abd El Aziz R, Kasim S, Gad L, Hassan D, Sabry S, et al.
Int J Clin Pract . 2022 Aug; 2022:4524637. PMID: 35936065
Results: HD and CKD groups had significantly higher endocan levels when compared with control group (median (IQR): 519.0 (202.3-742.0) versus 409.0 (245.3-505.3) and 273.0 (168.0-395.5) ng/L, respectively). Also, HD patients...